69 related articles for article (PubMed ID: 6108746)
1. Cardiovascular effects of bucindolol (MJ 13105) in conscious dogs.
Deitchman D; Byrne JE; Snyder RW
Arch Int Pharmacodyn Ther; 1980 Sep; 247(1):76-88. PubMed ID: 6108746
[TBL] [Abstract][Full Text] [Related]
2. Studies in the rat on bucindolol, a new antihypertensive agent with beta-adrenoceptor blocking properties.
Oates HF; Stoker LM; Stokes GS
Arch Int Pharmacodyn Ther; 1981 May; 251(1):95-102. PubMed ID: 6114719
[TBL] [Abstract][Full Text] [Related]
3. Hypotensive action of propranolol and a new beta-blocking agent, D-32 in conscious normotensive and renal hypertensive dogs.
Himori N; Izumi A; Hiramatsu Y
Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):4-18. PubMed ID: 8021
[TBL] [Abstract][Full Text] [Related]
4. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
Himori N; Ishimori T; Izumi A; Hiramatsu Y
Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
[TBL] [Abstract][Full Text] [Related]
5. Some cardiovascular effects of timolol a new beta-adrenergic blocking agent.
Scriabine A; Torchiana ML; Stavorski JM; Ludden CT; Minsker DH; Stone CA
Arch Int Pharmacodyn Ther; 1973 Sep; 205(1):76-93. PubMed ID: 4148410
[No Abstract] [Full Text] [Related]
6. Beta-adrenoceptor and cardiovascular effects of MJ 13105 (bucindolol) in anesthetized dogs and rats.
Deitchman D; Perhach JL; Snyder RW
Eur J Pharmacol; 1980 Feb; 61(3):263-77. PubMed ID: 6102523
[No Abstract] [Full Text] [Related]
7. Comparison of the haemodynamic effects of bucindolol, propranolol and pindolol in healthy volunteers.
O'Connor PC; Finch MJ; Harron DW; Meredith PA; McDevitt DG; Shanks RG
Br J Clin Pharmacol; 1985 Dec; 20(6):659-67. PubMed ID: 2868744
[TBL] [Abstract][Full Text] [Related]
8. Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
Maack C; Böhm M; Vlaskin L; Dabew E; Lorenz K; Schäfers HJ; Lohse MJ; Engelhardt S
Circulation; 2003 Jul; 108(3):348-53. PubMed ID: 12847069
[TBL] [Abstract][Full Text] [Related]
9. Bucindolol in essential hypertension.
Reid JL; Curzio J; Vincent J
Int J Clin Pharmacol Res; 1985; 5(5):293-301. PubMed ID: 2866166
[TBL] [Abstract][Full Text] [Related]
10. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
De Pauw M; Vilaine JP; Heyndrickx GR
Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular actions of dopexamine in anaesthetized and conscious dogs.
Einstein R; Abdul-Hussein N; Wong TW; Chang DH; Matthews R; Richardson DP
Br J Pharmacol; 1994 Jan; 111(1):199-204. PubMed ID: 7912154
[TBL] [Abstract][Full Text] [Related]
12. Extremely long-acting antihypertensive effects of KF-4317, a alpha- and beta 1-adrenoceptor blocker.
Kubo K; Ikeda J; Nakamura J; Nakamizo N
Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):140-60. PubMed ID: 2865934
[TBL] [Abstract][Full Text] [Related]
13. [Hemodynamic action of talinolol (Cordanum, 02-115), a new beta-receptor blocking substance, in man].
Wolf P; Feller K; Femmer K
Pharmazie; 1975 Oct; 30(10):678-81. PubMed ID: 696
[No Abstract] [Full Text] [Related]
14. Beneficial effects of bucindolol in a canine model of pentobarbital-induced heart failure.
Deitchman D; Snyder RW
Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):65-72. PubMed ID: 7271381
[TBL] [Abstract][Full Text] [Related]
15. Systemic haemodynamic and beta-adrenoceptor antagonistic effects of bisoprolol in conscious pigs: a comparison with propranolol.
Duncker DJ; Saxena PR; Verdouw PD
Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):54-63. PubMed ID: 2895611
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of bucindolol in isolated canine vascular smooth muscle.
Rimele TJ; Aarhus LL; Lorenz RR; Rooke TW; Vanhoutte PM
J Pharmacol Exp Ther; 1984 Nov; 231(2):317-25. PubMed ID: 6149305
[TBL] [Abstract][Full Text] [Related]
17. Hemodynamic effects of arotinolol in anesthetized dogs and its affinities for adrenoceptors in vitro.
Hashimoto H; Asano M; Hayashi T; Oguro K; Takiguchi Y; Nakashima M
Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):23-34. PubMed ID: 6202253
[TBL] [Abstract][Full Text] [Related]
18. Comparative beta-adrenoceptor blocking effect and pharmacokinetics of bucindolol and propranolol in man.
Maury M; Berdeaux A; Kher A; Duhaze P; Giudicelli JF
Eur J Clin Pharmacol; 1985; 27(6):649-56. PubMed ID: 2859199
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties.
Weber MA; Stokes GS; Gain JM
J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950
[TBL] [Abstract][Full Text] [Related]
20. [On the cardiovascular and beta-adrenergic blocking effects produced in the beagle dog by repeated oral administration of talinolol (Cordanum) and propranolol (author's transl)].
Heer S; Femmer K
Pharmazie; 1980; 34(5-6):317-20. PubMed ID: 6106208
[No Abstract] [Full Text] [Related]
[Next] [New Search]
